Cancer Clinical Trials Financial Reimbursement Program
Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · May 27, 2022
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping people with cancer who are participating in clinical trials by offering financial support and outreach. The goal is to see how this program can improve the number of participants in cancer clinical trials and understand what helps or makes it harder for people to join. The program will be implemented at the Harold C. Simmons Comprehensive Cancer Center.
To be eligible for this trial, participants must be enrolled in a therapeutic cancer clinical trial and speak either English or Spanish. If you qualify, you can expect to receive support that may help with the costs associated with being part of a clinical trial. This trial is currently recruiting participants aged 65 to 74, and it welcomes people of all genders. If you or someone you know is interested in joining, this program aims to make participation in cancer research more accessible and supportive.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be enrolled in a therapeutic cancer clinical trial
- • Speak English or Spanish
- Exclusion Criteria:
- • Not enrolled in a clinical trial
- • Does not speak English or Spanish
About University Of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical excellence. With a strong emphasis on translational medicine, the center conducts cutting-edge clinical trials aimed at developing novel therapies and improving patient outcomes across a wide range of diseases. Its multidisciplinary approach leverages a collaborative network of renowned faculty, state-of-the-art facilities, and a commitment to ethical research practices, positioning UT Southwestern at the forefront of medical discovery and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Trial Officials
David E Gerber, MD
Principal Investigator
Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials